GENEART THE GENE OF YOUR CHOICE
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

GENEART THE GENE OF YOUR CHOICE Trademark

Serial Number: 77294622 • Registration: 3691012

GENEART THE GENE OF YOUR CHOICE is a trademark filed by THERMO FISHER SCIENTIFIC GENEART GMBH on October 2, 2007. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 7 (Machinery), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

THERMO FISHER SCIENTIFIC GENEART GMBH (4 trademarks)

SANTA CLARA, CA 95051

Entity Type: 16

Geneart AG (7 trademarks)

Josef-Engert-Str. 11
Regensburg 93053 , DE

Entity Type: 03

Trademark Details

Filing Date

October 2, 2007

Registration Date

October 6, 2009

Published for Opposition

July 21, 2009

Cancellation Date

June 5, 2020

Goods & Services

Scientific and laboratory equipment, namely, automatic machines for the synthesis of deoxyribonucleic acids; robot machines for laboratory purposes; computer terminals; computer programs for use as tools for design and synthesis of deoxyribonucleic acids, genes and proteins; computer software to increase potency of enzymes and enzyme preparations, bacteria preparations, bacteriological preparations, micro-organism cultures, biological preparations and diagnostic preparations; computer operating programs; computer keyboards; blank magnetic data carriers; blank optical disks; computer memories; blank floppy disks; blank hard drives for computers; printers for use with computers; computer interfaces; laptop computers; data processors, namely, readers and scanners; computer mouse; microprocessors in the nature of semiconductors; computer modems; computer monitors; computer hardware; and notebook computers

Automatic machines for the synthesis of deoxyribonucleic acid; machine housings; pump membranes being pump diaphragms; regulators being part of machines; pressure regulators being part of machines; industrial robots

Medicines for human-medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; medicines for dental purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, Alzheimer's and infectious diseases; medicines for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; bacteriological preparations for medical and veterinary purposes for use in the treatment of cancer, high blood pressure, diarrhea, skin irritations, infections, diabetes, autoimmune diseases and arthritis as well as for use in gene therapy; biological preparations for medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; biological preparations for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; germicides for medical and laboratory equipment and for institutional and domestic uses; vermicides for medical and laboratory equipment and for institutional, domestic and residential uses; fungicides for medical and laboratory equipment and for institutional and domestic uses; deoxyribonucleic acid, namely, deoxyribonucleic acid comprising 80 to 150 base pairs for diagnostic medical purposes; and genes, namely, genes comprising 80 to 150 base pairs for medical diagnostic purposes

Chemical preparations for laboratory analysis in the field of biotechnology, drug discovery, genomics, molecular biology and microbiology; chemical preparations for scientific purposes in the field of biotechnology, drug discovery, genomics, molecular biology and microbiology; bacteria preparations for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; bacteriological preparations for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; micro-organism cultures for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; biochemical catalysts for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; biological materials for clinical, scientific, research and medical laboratories, namely, proteins, DNA, RNA and modifications thereof; diagnostic materials for scientific and research purposes, namely, proteins, DNA, RNA and modifications thereof; enzymes and enzyme preparations for use in the field of food manufacture, waste treatment, fermentation, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; biological materials for medical diagnostic laboratories, namely, proteins, DNA, RNA and modifications thereof; diagnostic materials for clinical and medical laboratory purposes, namely, proteins, DNA, RNA and modifications thereof

Computer services, namely, updating of computer software for others, consulting in the field of biotechnology, designing computer software for others, maintenance of computer software for others, leasing of computer software; computer programming for others, leasing of computers, and reconstruction of computer data for others; chemical analysis for others; research for others in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering, and machine engineering; laboratory services, namely, DNA engineering and processing for others in the fields of bacteriology, biology, genealogy and chemistry; consultation in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics research, engineering and machine engineering; consultation in the field of pharmacology; measuring calibration for others; development and research of new products for others; technical consultation in the field of environmental protection, namely, consultation relating to scientific research in the field of environmental protection; technical project planning and consulting services in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics research, engineering, and machine engineering; and quality control for others

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jun 5, 2020 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Oct 6, 2018 REM2
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 2, 2016 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Nov 27, 2015 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 27, 2015 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 27, 2015 APRE
TEAS SECTION 8 & 15 RECEIVED
Oct 6, 2015 E815
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 23, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 23, 2014 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 21, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 21, 2011 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 2, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 2, 2011 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 1, 2011 TCCA
REGISTERED-PRINCIPAL REGISTER
Oct 6, 2009 R.PR
PUBLISHED FOR OPPOSITION
Jul 21, 2009 PUBO
NOTICE OF PUBLICATION
Jul 1, 2009 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 17, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 10, 2009 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 10, 2009 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 10, 2009 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 10, 2009 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 10, 2009 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 8, 2009 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 16, 2009 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 5, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2009 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 29, 2009 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 29, 2009 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 29, 2009 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 29, 2009 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 15, 2009 GNRN
NON-FINAL ACTION E-MAILED
Apr 15, 2009 GNRT
NON-FINAL ACTION WRITTEN
Apr 15, 2009 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 25, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 25, 2009 CRFA
ASSIGNED TO LIE
Mar 24, 2009 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 24, 2009 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 25, 2008 GNRN
NON-FINAL ACTION E-MAILED
Sep 25, 2008 GNRT
NON-FINAL ACTION WRITTEN
Sep 25, 2008 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 3, 2008 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 3, 2008 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 1, 2008 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 1, 2008 GNSL
SUSPENSION LETTER WRITTEN
Aug 1, 2008 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 10, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 10, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 10, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 10, 2008 GNRN
NON-FINAL ACTION E-MAILED
Jan 10, 2008 GNRT
NON-FINAL ACTION WRITTEN
Jan 10, 2008 CNRT
ASSIGNED TO EXAMINER
Jan 7, 2008 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Oct 10, 2007 MDSC
NEW APPLICATION ENTERED
Oct 9, 2007 NWAP